Table 5. Adverse effects of vitamin C reported in the literature.
# | Type of Side Effect | Patient Details | Vitamin C Dose | Clinical Details | Outcome (and reference) | |
Pre Vitamin C Treatment | Post Vitamin C Treatment | |||||
1 | Acute Renal Failure | 70 M | 2.5g IV×1 dose | Creatinine 5.0 | Flank pain, hematuria. Creatinine 10. | Permanent renal failure(24) |
Renal biopsy – Calcium oxalate crystals in tubular lumen | ||||||
2 | 58 F | 45g IV×1 dose | Nephrotic syndrome | Oliguria. Treated with dopamine and hemodialysis. After first dialysis plasma vitamin C 15.4mg/dl (0.87mM), oxalate 2.3mg/dl. Intractable ventricular fibrillation. Post mortem- intra tubular calcium oxalate crystals. | Died(22) | |
Creatinine 0.8 | ||||||
3 | 61 M | 60g IV×1 dose | Metastatic prostate cancer | Anuric. Creatinine 13.4. Plasma vitamin C 116.2mg/dl (6.6mM). Treated with nephrostomy and forced diuresis. Renal biopsy - acute tubular necrosis and extensive oxalate deposition | Recovered(23) | |
Obstructive uropathy | ||||||
Creatinine 0.7 | ||||||
4 | Hemolysis in Patients with Glucose-6-Phosphate Dehydrogenase Deficiency | 68 M | 80g IV×2 days | Second degree burns of one hand | Hemoglobin 5.8. Retics 5.9%. Anuria, creatinine 13.8. Coma, hemiparesis, possible intravascular coagulation. Supportive treatment and hemodialysis. | Died on day 22(25) |
5 | 32 M | 40g IV 3×/wk 20–40g/day oral×1 month then 80g IV×1 dose | HIV | Breathlessness, fever, dark urine. Hemoglobin 6.7 Retics 15.6%. Bilirubin 3.16. Conservative treatment with high fluid intake | Recovered(26) |
Normal ranges and units of measurement for laboratory values are: Serum creatinine - mg/dl (normal range 0.6–1.5mg/dl). Hemoglobin g/dl (normal range: male 13–18g/dl, female 12–16g/dl). Reticulocyte count in % (normal range 0.5–2.5% red cells). Plasma bilirubin- mg/dl (normal range <1mg/dl). Plasma vitamin C - mg/dl (normal range 0.6–2 mg/dl).